ArticleSleep & breathing = Schlaf & Atmung2025
Oxidative stress in patients with nasal respiratory impairment and OSAS.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study focused on evaluating the clinical significance of oxidative stress biomarkers in patients with OSAS. We investigated how nasal respiratory obstruction in OSAS patients might affect the oxidative balance.
methodsSixty patients were divided into three groups (n = 20 each): severe OSAS (AHI > 30), snoring with AHI < 15 (mild OSAS), and nasal respiratory impairment with AHI < 5. All subjects underwent ENT examination, rhinomanometry, polysomnography, and oxidative stress biomarker analysis.
resultsFrom the measurements of biomarkers associated with oxidative stress, specifically NPBI (non-protein bound iron), AOPP (Advanced Oxidation Protein Products), Isoprostanes (both plasmatic ad urinary), and Thiols, no statistically significant differences emerged among the subjects belonging to the three groups (patients with OSAS, subjects with snoring and AHI < 15, subjects with nasal respiratory impairment only and AHI < 5).
conclusionsThe presence of oxidative stress markers in patients with nasal obstruction, even in the absence of severe OSAS, highlights the potential role of nasal airflow limitation as a contributing factor in the pathogenesis of sleep-disordered breathing. A better understanding of the oxidative stress profile in these conditions might contribute to refining diagnostic and therapeutic approaches, and potentially reduce the reliance on polysomnography in selected cases.
Indexed as
Identifiers
40387971What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.